Annual Report

ARROWHEAD PHARMACEUTICALS, INC. Filed 2023-11-29 Acc 0001628280-23-040219

Documents 1

2024-11-26 10-K Annual Report
2023-12-05 8-K Auditor change
2023-11-29 8-K Results of operations
2023-11-29 10-K Annual Report
2023-11-22 4 Chief Medical Officer sold 19,700 shares at an average $28.80 ($567,315)
2022-11-28 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading arwr-20230930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…